MOther-Child Interaction Assessment TRAINING for Pediatricians
Launched by UNIVERSITY HOSPITAL, LILLE · Sep 28, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The MOCITRAINING study is looking at how pediatricians can better support the relationship between mothers and their babies, especially during the first month after birth. The goal is to see if teaching doctors to focus on both the mother and child together during visits can improve their interactions and overall well-being in the short and medium term. This study is important because strong mother-child relationships are crucial for the child’s development and can help address issues like child behavior disorders and maternal depression.
To participate in this study, mothers and their one-month-old (plus or minus 15 days) biological children can join, but mothers need to be able to read French and provide consent after being fully informed about the study. Unfortunately, preterm babies, twins, or those with certain medical conditions won’t be eligible. If you join the study, you can expect to take part in a program designed to enhance your interactions with your child, and you’ll have the support of healthcare professionals throughout the process.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Each child will be included WITH his biological mother at the first-month visit after birth.
- • Age: 1 month + / - 15 days (child), accompanied by his biological mother
- • Mother able to read French;
- • Signed consent letter after complete information of parents about the MOCITRAINING study, its principle, advantages and disadvantages.
- Exclusion Criteria:
- • Preterm babies.
- • Children from a twin or multiple pregnancy.
- • Children with somatic diagnosis explaining the presence of digestive, sleeping or interactional disorders.
- • Refusal to participate after clear information about the study;
- • Refusal to sign the consent letter;
- • Refusal to be informed of a diagnostic hypothesis;
- • Participants not covered by the Social Security system;
- • Participants incapable of consenting or under legal protection (guardianship or curatorship).
About University Hospital, Lille
University Hospital Lille is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the hospital leverages its extensive resources, multidisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking studies across various medical fields. Committed to enhancing therapeutic options and improving patient outcomes, University Hospital Lille collaborates with researchers, healthcare professionals, and industry partners to ensure rigorous scientific standards and ethical practices in all clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lille, , France
Patients applied
Trial Officials
Renaud Jardri, MD, PhD
Principal Investigator
University Hospital, Lille
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials